Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-14 Purchase |
2025-03-19 7:40 pm |
OptimizeRx Corp | OPRX | Lang James Paul Director |
321,408 | $7.6033 | $2,443,761 | 389,452 (Direct) |
View |
| 2024-12-12 Purchase |
2024-12-16 2:28 pm |
OptimizeRx Corp | OPRX | FEBBO WILLIAM J CEO |
20,000 | $5.011 | $100,220 | 601,253 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-01 Tax Withholding |
2025-03-04 09:18 am |
N/A N/A |
OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer |
572 | $5.18 | 121,314 (Direct) |
View |
| 2025-03-01 Exercise |
2025-03-04 09:18 am |
N/A N/A |
OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer |
1,928 | $0 | 121,314 (Direct) |
View |
| 2025-03-01 Tax Withholding |
2025-03-04 09:16 am |
N/A N/A |
OptimizeRx Corp | OPRX | Odence-Ford Marion Chief Legal Officer & CHRO |
268 | $5.18 | 70,276 (Direct) |
View |
| 2025-03-01 Exercise |
2025-03-04 09:16 am |
N/A N/A |
OptimizeRx Corp | OPRX | Odence-Ford Marion Chief Legal Officer & CHRO |
771 | $0 | 70,276 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-20 1:40 pm |
N/A N/A |
OptimizeRx Corp | OPRX | FEBBO WILLIAM J CEO |
401 | $6.64 | 600,852 (Direct) |
View |
| 2025-02-15 Tax Withholding |
2025-02-20 1:40 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
2,156 | $6.64 | 95,139 (Direct) |
View |
| 2025-02-15 Tax Withholding |
2025-02-20 1:39 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer |
1,386 | $6.64 | 51,605 (Direct) |
View |
| 2025-02-15 Tax Withholding |
2025-02-20 1:39 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer |
2,298 | $6.64 | 119,958 (Direct) |
View |
| 2025-02-15 Tax Withholding |
2025-02-20 1:38 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Odence-Ford Marion Chief Legal Officer & CHRO |
1,479 | $6.64 | 69,773 (Direct) |
View |
| 2025-02-11 Tax Withholding |
2025-02-13 3:58 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO |
1,386 | $5.6 | 83,252 (Direct) |
View |
| 2025-02-11 Exercise |
2025-02-13 3:58 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO |
4,000 | $0 | 83,252 (Direct) |
View |
| 2025-02-02 Exercise |
2025-02-04 6:50 pm |
2025-02-02 2025-02-02 |
OptimizeRx Corp | OPRX | KLEMA CATHY Director |
5,109 | $0 | 11,752 (Direct) |
View |
| 2024-12-23 Option Award |
2024-12-27 5:00 pm |
2025-12-23 2027-12-23 |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
119,150 | $0 | 175,037 (Direct) |
View |
| 2024-02-15 Option Award(A) |
2024-12-27 4:38 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
0 | $0 | 33,365 (Direct) |
View |
| 2024-12-23 Option Award |
2024-12-27 3:18 pm |
2025-12-23 2027-12-23 |
OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer |
119,150 | $0 | 199,998 (Direct) |
View |
| 2024-12-23 Option Award |
2024-12-27 2:09 pm |
2025-12-23 2027-12-23 |
OptimizeRx Corp | OPRX | Greco Theresa Chief Commercial Officer |
44,681 | $0 | 80,026 (Direct) |
View |
| 2024-12-23 Option Award |
2024-12-27 2:08 pm |
2025-12-23 2027-12-23 |
OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO |
119,150 | $0 | 146,380 (Direct) |
View |
| 2024-12-23 Option Award |
2024-12-27 2:08 pm |
2025-12-23 2027-12-23 |
OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer |
119,150 | $0 | 130,733 (Direct) |
View |
| 2024-12-20 Tax Withholding |
2024-12-20 7:48 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO |
1,153 | $4.75 | 35,086 (Direct) |
View |
| 2024-12-19 Exercise |
2024-12-20 7:48 pm |
2024-12-19 2026-12-19 |
OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO |
3,927 | $0 | 35,086 (Direct) |
View |
| 2024-12-19 Tax Withholding |
2024-12-20 7:47 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer |
2,576 | $4.75 | 93,941 (Direct) |
View |
| 2024-12-19 Exercise |
2024-12-20 7:47 pm |
N/A 2026-12-19 |
OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer |
6,546 | $0 | 93,941 (Direct) |
View |
| 2024-12-19 Tax Withholding |
2024-12-20 7:47 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer |
577 | $4.75 | 15,511 (Direct) |
View |
| 2024-12-19 Exercise |
2024-12-20 7:47 pm |
N/A 2026-12-19 |
OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer |
1,964 | $0 | 15,511 (Direct) |
View |
| 2024-12-19 Tax Withholding |
2024-12-20 7:46 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
1,316 | $4.75 | 47,761 (Direct) |
View |
| 2024-12-19 Exercise |
2024-12-20 7:46 pm |
N/A 2026-12-19 |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
5,237 | $0 | 47,761 (Direct) |
View |
| 2024-11-08 Tax Withholding |
2024-11-12 09:37 am |
N/A N/A |
OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO |
524 | $6.27 | 24,456 (Direct) |
View |
| 2024-11-08 Exercise |
2024-11-12 09:37 am |
N/A N/A |
OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO |
1,785 | $0 | 24,456 (Direct) |
View |
| 2024-11-01 Tax Withholding |
2024-11-05 8:30 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Greco Theresa Chief Commercial Officer |
1,693 | $5.15 | 35,345 (Direct) |
View |
| 2024-10-11 Tax Withholding |
2024-10-15 4:53 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
2,066 | $6.63 | 33,366 (Direct) |
View |
| 2024-10-11 Exercise |
2024-10-15 4:53 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
8,222 | $0 | 33,366 (Direct) |
View |
| 2024-10-03 Tax Withholding |
2024-10-07 9:30 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
4,177 | $7.83 | 43,793 (Direct) |
View |
| 2024-10-03 Exercise |
2024-10-07 9:30 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
16,622 | $0 | 43,793 (Direct) |
View |
| 2024-10-03 Tax Withholding |
2024-10-07 9:26 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO |
1,952 | $7.83 | 29,844 (Direct) |
View |
| 2024-10-03 Exercise |
2024-10-07 9:26 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO |
6,649 | $0 | 29,844 (Direct) |
View |
| 2024-10-03 Tax Withholding |
2024-10-07 9:24 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer |
2,617 | $7.83 | 83,527 (Direct) |
View |
| 2024-10-03 Exercise |
2024-10-07 9:24 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer |
6,649 | $0 | 83,527 (Direct) |
View |
| 2024-10-03 Tax Withholding |
2024-10-07 9:24 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer |
976 | $7.83 | 13,521 (Direct) |
View |
| 2024-10-03 Exercise |
2024-10-07 9:24 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer |
3,324 | $0 | 13,521 (Direct) |
View |
| 2024-08-02 Option Award |
2024-08-05 5:22 pm |
2025-08-02 2027-08-02 |
OptimizeRx Corp | OPRX | McCarthy Brian Clark Chief Revenue Officer |
28,210 | $0 | 28,210 (Direct) |
View |
Ownership |
2024-08-05 4:57 pm |
N/A N/A |
OptimizeRx Corp | OPRX | McCarthy Brian Clark Chief Revenue Officer |
0 | $0 | 0 (Direct) |
View |
| 2024-04-18 Tax Withholding |
2024-06-12 11:41 am |
N/A N/A |
OptimizeRx Corp | OPRX | FEBBO WILLIAM J CEO |
782 | $9.35 | 639,043 (Direct) |
View |
| 2024-04-18 Exercise |
2024-06-12 11:41 am |
N/A N/A |
OptimizeRx Corp | OPRX | FEBBO WILLIAM J CEO |
28,895 | $0 | 639,043 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-11 5:50 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Spangler Patrick D Director |
13,286 | $0 | 45,467 (Direct) |
View |
| 2024-06-05 Exercise |
2024-06-11 5:50 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Spangler Patrick D Director |
10,061 | $0 | 45,467 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-11 5:49 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Vos Ellen O'Connor Director |
13,286 | $0 | 62,774 (Direct) |
View |
| 2024-06-05 Exercise |
2024-06-11 5:49 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Vos Ellen O'Connor Director |
10,061 | $0 | 62,774 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-11 5:48 pm |
N/A N/A |
OptimizeRx Corp | OPRX | WASSON GREGORY D Director |
13,286 | $0 | 47,315 (Direct) |
View |
| 2024-06-05 Exercise |
2024-06-11 5:48 pm |
N/A N/A |
OptimizeRx Corp | OPRX | WASSON GREGORY D Director |
10,061 | $0 | 47,315 (Direct) |
View |
| 2024-06-05 Exercise |
2024-06-11 5:48 pm |
N/A N/A |
OptimizeRx Corp | OPRX | HALAS GUS D Director |
10,061 | $0 | 80,926 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-11 5:47 pm |
N/A N/A |
OptimizeRx Corp | OPRX | KLEMA CATHY Director |
6,643 | $0 | 6,643 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-11 5:46 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Lang James Paul Director |
13,286 | $0 | 68,044 (Direct) |
View |
| 2024-06-05 Exercise |
2024-06-11 5:46 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Lang James Paul Director |
10,061 | $0 | 68,044 (Direct) |
View |
| 2024-05-02 Tax Withholding |
2024-05-06 9:35 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer |
35,415 | $10.7 | 72,846 (Direct) |
View |
| 2024-05-02 Exercise |
2024-05-06 9:35 pm |
2024-05-02 2024-05-02 |
OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer |
90,000 | $0 | 72,846 (Direct) |
View |
| 2024-03-01 Tax Withholding(A) |
2024-05-06 9:34 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer |
572 | $15.95 | 18,261 (Direct) |
View |
| 2024-03-01 Exercise(A) |
2024-05-06 9:34 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer |
1,927 | $0 | 18,261 (Direct) |
View |
| 2024-02-15 Option Award(A) |
2024-05-06 9:32 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer |
7,750 | $0 | 16,906 (Direct) |
View |